Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape-Reference-Cited by-同舟云学术

Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape

Published:2020-04-19 Issue:5 Volume:13 Page:519-532
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Shapiro Roman M.¹,Antin Joseph H.²

Affiliation:

1. Advanced Fellow in Stem Cell Transplantation, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA

2. Blood and Marrow Transplantation Program, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2020.1752175

Reference98 articles.

1. Acute Graft Versus Host Disease: A Comprehensive Review

2. Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

3. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

4. Classification systems for chronic graft-versus-host disease

5. Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term CXCR3 antagonist AMG487 mitigated acute graft-versus-host disease by inhibiting T cell activation in a murine model;Transplant Immunology;2024-12

2. Peptibodies: Bridging the gap between peptides and antibodies;International Journal of Biological Macromolecules;2024-10

3. Grading Histopathology Features of Graft-versus-host Disease in Animal Models; A Systematic Review;Iranian Journal of Allergy, Asthma and Immunology;2024-06-05

4. Triazole antifungal drug interactions—practical considerations for excellent prescribing;Journal of Antimicrobial Chemotherapy;2024-04-17

5. Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease;Nature Communications;2024-04-15